Compare PCF & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCF | HSDT |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.4M | 123.1M |
| IPO Year | N/A | N/A |
| Metric | PCF | HSDT |
|---|---|---|
| Price | $6.12 | $2.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 74.8K | ★ 567.9K |
| Earning Date | 01-01-0001 | 11-18-2025 |
| Dividend Yield | ★ 10.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $941,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $75.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 87.45 |
| 52 Week Low | $5.71 | $2.62 |
| 52 Week High | $6.96 | $1,200.00 |
| Indicator | PCF | HSDT |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 37.58 |
| Support Level | $6.08 | $2.62 |
| Resistance Level | $6.15 | $3.07 |
| Average True Range (ATR) | 0.05 | 0.29 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 60.48 | 31.43 |
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.